- Home
- BRKR vs HALO Comparison
BRKR vs HALO Comparison
Compare BRKR & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRKR | HALO |
|---|---|---|
| Founded | 1960 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3B | 8.5B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | BRKR | HALO |
|---|---|---|
| Price | $50.62 | $70.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 12 |
| Target Price | $51.69 | ★ $76.42 |
| AVG Volume (30 Days) | ★ 2.3M | 1.8M |
| Earning Date | 02-12-2026 | 02-17-2026 |
| Dividend Yield | ★ 0.41% | N/A |
| EPS Growth | N/A | ★ 56.68 |
| EPS | N/A | ★ 4.74 |
| Revenue | ★ $3,438,900,000.00 | $1,242,852,000.00 |
| Revenue This Year | $3.58 | $34.54 |
| Revenue Next Year | $1.46 | $26.28 |
| P/E Ratio | ★ N/A | $15.04 |
| Revenue Growth | 6.10 | ★ 31.19 |
| 52 Week Low | $28.53 | $47.50 |
| 52 Week High | $61.01 | $79.50 |
Technical Indicators
Market Signals| Indicator | BRKR | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 54.02 | 52.04 |
| Support Level | $47.84 | $70.75 |
| Resistance Level | $56.22 | $74.08 |
| Average True Range (ATR) | 2.35 | 2.07 |
| MACD | -0.38 | -0.07 |
| Stochastic Oscillator | 35.53 | 40.32 |
Price Performance
Historical ComparisonAbout BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.